News

OBI’s company English name official renamed OBI Pharma, Inc.

2013-01-18

Breast Cancer New Drug: OBI-822/821 received Taiwan FDA Approval for entering Phase III trial

Breast Cancer New Drug:OBI-822/821 received Taiwan FDA Approval for entering …

2012-08-08

DIFICID (Fidaxomicin) Approved by Taiwan Department of Health for the Treatment of CDAD

DIFICID® (Fidaxomicin) Approved by Taiwan Department of Health for the …

2012-07-20